STEPHANIE SHAHEEN: Open Payments
NPI 1669857017 · TROY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 16 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $389
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 5 | $182 |
| Novo Nordisk Inc | 3 | $61 |
| JAZZ PHARMACEUTICALS INC. | 2 | $41 |
| Xeris Pharmaceuticals, Inc. | 2 | $34 |
| Lilly USA, LLC | 2 | $32 |
| Chiesi USA, Inc. | 1 | $22 |
| Rhythm Pharmaceuticals, Inc. | 1 | $16 |
Products named: REZDIFFRA, Wegovy, XYWAV, RECORLEV, MYALEPT, Rybelsus, ZEPBOUND, IMCIVREE.
Industry payments across MI — which companies pay providers there.
